Screener
PJP vs PPH
Invesco Pharmaceuticals ETF vs VanEck Pharmaceutical ETF
Key differences
- PPH costs 0.21% less per year.
- Over the last 3 years, PJP has delivered higher annualized returns.
- PJP has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| PJP | PPH | |
|---|---|---|
| Annual cost (TER) | 0.57% | 0.36% |
| Fund size (AUM) | $334M | $966M |
| Since | 2005 | 2011 |
| Dividend yield | 1.01% | 2.12% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +38.9% | +24.5% |
| CAGR 3Y | +14.0% | +12.6% |
| CAGR 5Y | +7.4% | +9.8% |
| Sharpe 3Y | 0.69 | 0.63 |
| Volatility 1Y | 16.19% | 17.07% |
| Max drawdown | -33.95% | -29.70% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PJP and PPH
Explore further